Columbia Care To Raise $25.2 Million In Bought Deal Financing

Columbia Care (CSE: CCHW) is the latest firm to announce a financing. The company this morning announced that it will be conducting a bought deal financing to raise gross proceeds of $25.2 million in a financing lad by Canaccord Genuity.

The financing will see a total of 2.8 million shares of the issuer sold at a price of $9.00 per share to raise gross proceeds of $25.2 million. No warrant is to be issued in connection with the offering, with the offering expected to be sold primarily to one large institutional investor, however a name was not provided.

An over-allotment option has also been granted by the company, valid until the closing of the offering.

Proceeds from the financing are to be used for working capital and general corporate purposes.

The financing is expected to close February 25, 2021.

Columbia Care last traded at $9.78 on the CSE.


Information for this briefing was found via Sedar and Columbia Care Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Are Commodities Entering a Generational Cycle? | Terry Lynch

Is the Gold Boom Still in the ‘Pre-Party’ Phase? | Sean Kingsley

The Hidden Environmental Cost of Fertilizer | Robin Dow

Recommended

Ottawa Backs First Phosphate Battery Grade Validation Push With $16.7M Boost

First Majestic Drills 3.43 g/t Gold Over 24.4 Metres At Jerritt Canyon

Related News

Columbia Care Reports Preliminary Q4 Revenues Of $76.1 Million, Provides 2021 Guidance

Columbia Care (CSE: CCHW) this morning reported preliminary fourth quarter and full year 2020 financial...

Wednesday, March 3, 2021, 09:38:22 AM

Columbia Care Reports $132.3 Million In Q3 Revenues, Lowers 2021 Guidance

Columbia Care (NEO: CCHW) reported its third quarter financial results this morning, posting record quarterly...

Friday, November 12, 2021, 09:11:20 AM

US Cannabis: Earnings Preview For The Oncoming Fourth Quarter Results

March is turning out to be a busy month in public cannabis, with many of...

Monday, March 8, 2021, 04:10:00 PM

Columbia Care: Canaccord Drops Price Target To $13

On November 12th, Columbia Care (NEO: CCHW) reported its third quarter financial results. The company...

Sunday, November 21, 2021, 04:52:00 PM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM